Palisade Bio, Inc. - Common Stock (NQ:PALI)
All News about Palisade Bio, Inc. - Common Stock
Palisade Bio Advances PALI-2108 Into Phase II for Ulcerative Colitis and Crohn’s ↗
September 27, 2026
Via MarketBeat
What's going on in today's after hours session ↗
April 20, 2026
Via Chartmill